1-3 of 3
Yanxia Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A235: Anti-CSF-1R antibodies reduce tumor-associated macrophages and inhibit tumor growth in preclinical models.

Yanxia Li, Sneha Mathew, Lan Wu, Ying Wang, Kris Persaud, Douglas Burtrum, Paul Balderes, David Surguladze, John Haurum, Dale Ludwig, Jacqueline Doody
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): A235.
https://doi.org/10.1158/1535-7163.TARG-13-A235
Published: 01 November 2013
View article titled, Abstract A235: Anti-CSF-1R antibodies reduce tumor-associated macrophages and inhibit tumor growth in preclinical models.
Journal Articles

Abstract C224: Anti-CSF-1R antibodies reduce tumor-associated macrophages and inhibit tumor growth in preclinical models.

Yanxia Li, Sneha Mathew, Lan Wu, Ying Wang, Jessica Kearney, Kris Persaud, Douglas Burtrum, Paul Balderes, David Surguladze, James Tonra, John Haurum, Dale Ludwig, Jacqueline F. Doody
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): C224.
https://doi.org/10.1158/1535-7163.TARG-11-C224
Published: 12 November 2011
View article titled, Abstract C224: Anti-CSF-1R antibodies reduce tumor-associated macrophages and inhibit tumor growth in preclinical models.
Journal Articles

Inhibitory activity of cetuximab on epidermal growth factor receptor mutations in non–small cell lung cancers

Jacqueline F. Doody, Ying Wang, Sheetal N. Patel, Christopher Joynes, Sui Ping Lee, Jason Gerlak, Robin L. Rolser, Yanxia Li, Philipp Steiner, Rajiv Bassi, Dan J. Hicklin, Yaron R. Hadari
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (10): 2642–2651.
https://doi.org/10.1158/1535-7163.MCT-06-0506
Published: 15 October 2007
View article titled, Inhibitory activity of cetuximab on epidermal growth factor receptor mutations in non–small cell lung cancers
Open the PDF for Inhibitory activity of cetuximab on epidermal growth factor receptor mutations in non–small cell lung cancers in another window